Serotonin2 (5-HT2) receptor binding in the frontal cortex of schizophrenic patients

[1]  H. Meltzer,et al.  β-Adrenergic receptor binding in frontal cortex of suicide victims , 1991, Biological Psychiatry.

[2]  Anat Biegon,et al.  Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain postmortem , 1990, Brain Research.

[3]  J. Palacios,et al.  Dopamine receptors in human brain: Autoradiographic distribution of D2 sites , 1989, Neuroscience.

[4]  H. Meltzer,et al.  Classification of typical and atypical antipsychotic drugs on the basis of dopamine D-1, D-2 and serotonin2 pKi values. , 1989, The Journal of pharmacology and experimental therapeutics.

[5]  S. Peroutka,et al.  5‐Hydroxytryptamine receptor “families” , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[6]  A. M. Szczepanik,et al.  Effects of acute and chronic treatments with clozapine and haloperidol on serotonin (5-HT2) and dopamine (D2) receptors in the rat brain , 1989, Brain Research.

[7]  Frank Roels,et al.  Autoradiographic localization of D1 and D2 dopamine receptors in the human brain , 1988, Neuroscience Letters.

[8]  D. Weinberger,et al.  Physiological dysfunction of dorsolateral prefrontal cortex in schizophrenia. IV. Further evidence for regional and behavioral specificity. , 1988, Archives of general psychiatry.

[9]  C. Katona,et al.  Brain 5-HT2 receptor binding sites in depressed suicide victims , 1988, Brain Research.

[10]  C. Marsden,et al.  Pharmacological characterization of binding sites identified in rat brain following in vivo administration of [3H]‐spiperone. , 1987, British journal of pharmacology.

[11]  T. Kuno,et al.  Decreased serotonin S2 and increased dopamine D2 receptors in chronic schizophrenics , 1986, Biological Psychiatry.

[12]  B. McEwen,et al.  Increased serotonin2 and beta-adrenergic receptor binding in the frontal cortices of suicide victims. , 1986, Archives of general psychiatry.

[13]  B. Scatton,et al.  Autoradiographic localization and quantification of dopamine D2 receptors in normal human brain with [3H]N-n-propylnorapomorphine , 1986, Brain Research.

[14]  C. Altar,et al.  Typical and atypical antipsychotic occupancy of D2 and S2 receptors: An autoradiographic analysis in rat brain , 1986, Brain Research Bulletin.

[15]  D. Weinberger,et al.  Physiologic dysfunction of dorsolateral prefrontal cortex in schizophrenia. I. Regional cerebral blood flow evidence. , 1986, Archives of general psychiatry.

[16]  L. Snyder,et al.  Characterization and localization of serotonin receptors in human brain postmortem , 1986, Brain Research.

[17]  H. Meltzer,et al.  Differential Effect of Subchronic Treatment with Various Neuroleptic Agents on Serotonin2 Receptors in Rat Cerebral Cortex , 1986, Journal of neurochemistry.

[18]  G. Vauquelin,et al.  Regional distribution of the dopamine D2 receptors in the mesotelencephalic dopamine neuron system of human brain , 1985, Journal of the Neurological Sciences.

[19]  L. Potter,et al.  D-2 dopamine receptors in the frontal cortex of rat and human. , 1985, Life sciences.

[20]  J. Maloteaux,et al.  Regional and Cortical Laminar Distributions of Serotonin S2, Benzodiazepine, Muscarinic, and Dopamine D2 Receptors in Human Brain , 1984, Journal of neurochemistry.

[21]  S. Tang,et al.  Loxapine and clozapine decrease serotonin (S2) but do not elevate dopamine (D2) receptor numbers in the rat brain , 1984, Psychiatry Research.

[22]  A. Andorn,et al.  Specific [3H]-spiroperidol binding sites in human prefrontal cortex: potential site multiplicity and overall serotonin-like selectivity. , 1984, Life sciences.

[23]  J. Palacios,et al.  2-[125Iodo]LSD, a new ligand for the characterisation and localisation of 5-HT2 receptors , 1984, Naunyn-Schmiedeberg's Archives of Pharmacology.

[24]  J. Leysen,et al.  [3H]Ketanserin (R 41 468), a selective 3H-ligand for serotonin2 receptor binding sites. Binding properties, brain distribution, and functional role. , 1982, Molecular pharmacology.

[25]  J. V. van Beek,et al.  Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. , 1981, The Journal of pharmacology and experimental therapeutics.

[26]  F. Owen,et al.  Neurotransmitter receptors in brain in schizophrenia , 1981, Acta psychiatrica Scandinavica. Supplementum.

[27]  T. Crow,et al.  Tritiated LSD binding in frontal cortex in schizophrenia. , 1981, Archives of general psychiatry.

[28]  S. Peroutka,et al.  Relationship of neuroleptic drug effects at brain dopamine, serotonin, alpha-adrenergic, and histamine receptors to clinical potency. , 1980, The American journal of psychiatry.

[29]  S H Snyder,et al.  Multiple serotonin receptors: differential binding of [3H]5-hydroxytryptamine, [3H]lysergic acid diethylamide and [3H]spiroperidol. , 1979, Molecular pharmacology.

[30]  S. Snyder,et al.  Neurotransmitter receptors in frontal cortex of schizophrenics. , 1979, Archives of general psychiatry.

[31]  P. Seeman,et al.  Selective labeling of serotonin receptors by d-[3H]lysergic acid diethylamide in calf caudate. , 1978, Proceedings of the National Academy of Sciences of the United States of America.

[32]  L. Iversen,et al.  3H-Spiperone binding in normal and schizophrenic post-mortem human brain. , 1978, Life sciences.

[33]  M. Poulter,et al.  INCREASED DOPAMINE-RECEPTOR SENSITIVITY IN SCHIZOPHRENIA , 1978, The Lancet.

[34]  J. Leysen,et al.  A serotonergic component of neuroleptic receptors. , 1977, Archives internationales de pharmacodynamie et de therapie.

[35]  S. Snyder,et al.  Binding interactions of lysergic acid diethylamide and related agents with dopamine receptors in the brain. , 1976, Molecular pharmacology.

[36]  Oliver H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[37]  G. Scatchard,et al.  THE ATTRACTIONS OF PROTEINS FOR SMALL MOLECULES AND IONS , 1949 .

[38]  H. Meltzer,et al.  Clinical studies on the mechanism of action of clozapine: the dopamine-serotonin hypothesis of schizophrenia , 2004, Psychopharmacology.

[39]  S. Potkin,et al.  Chronic treatment with clozapine or haloperidol differentially regulates dopamine and serotonin receptors in rat brain , 1990, Synapse.

[40]  H. Meltzer,et al.  Serotonergic measures in the brains of suicide victims: 5-HT2 binding sites in the frontal cortex of suicide victims and control subjects. , 1989, The American journal of psychiatry.

[41]  H. Meltzer,et al.  Effect of typical and atypical antipsychotic drugs on 5-HT2 receptor density in rat cerebral cortex. , 1989, Life sciences.

[42]  R. Kahn,et al.  The role of serotonin in schizophrenia. , 1988, Schizophrenia bulletin.

[43]  H. Meltzer,et al.  Biological studies in schizophrenia. , 1987, Schizophrenia bulletin.

[44]  S. Levin.  Frontal lobe dysfunctions in schizophrenia--II. Impairments of psychological and brain functions. , 1984, Journal of psychiatric research.

[45]  L. Iversen,et al.  Preliminary studies of human cortical 5-HT2 receptors and their involvement in schizophrenia and neuroleptic drug action. , 1983, Journal of neural transmission. Supplementum.

[46]  T. Kuno,et al.  Evidence for the presence of D2 and 5-HT2 receptors in the human prefrontal cortex. , 1982, Japanese journal of pharmacology.